Dhampur Bio Organics share price today

Dhampur Bio Organics Ltd's share price was ₹131.80 at the close on 4 November 2026. It has been rising for 38 weeks. That is 16.9% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹71 and ₹141, and at that close it sat 87% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Dhampur Bio Organics Ltd is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 14 weeks in a row.

Over the last 4.2 years the share price moved −20% while the NIFTY 500 moved +40%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

One change stood out: profit up on a year earlier for 4 quarters in a row.

1. Profit up on a year earlier for 4 quarters in a row

   In the June 2026 quarter profit was ₹37 crore, +268.2% on a year earlier.

For April to June 2026 (the quarter ended 30 June 2026), Dhampur Bio Organics reported revenue of ₹533 crore, up 8.3% from ₹492 crore a year earlier, and a profit of ₹37.0 crore, against a loss of ₹22.0 crore a year earlier.

Dhampur Bio Organics results: April to June 2026 against a year earlier

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.

Dhampur Bio Organics closed at ₹131.80 on 4 November 2026, up 73.8% from ₹75.85 a year earlier (7 November 2025) and down 17.4% over three years. Its highest weekly close since September 2022 was ₹210.10 on 2 December 2022.

Dhampur Bio Organics share price: then and now

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

225 weekly closes from 9 September 2022 to 4 November 2026.

4 Nov 2026: Dhampur Bio Organics closed at ₹131.80, up 12.3% on the week and up 9.0% on the month. 17 Jul 2026: ex-date for a dividend of ₹1.50 a share.

Earlier

• Results for April to June 2026: Revenue up 8.3% on a year earlier.

Dhampur Bio Organics paid ₹1.50 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 1.14% at the ₹131.80 close on 4 November 2026. The last was a dividend of ₹1.50 a share, ex-date 17 July 2026.

Dhampur Bio Organics dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here.

Yes. Dhampur Bio Organics Ltd paid out 40% of its profit as dividends in FY26, and it paid a dividend in 4 of its last 6 reported years.

From the NSE corporate-actions record, read 5 November 2026.

Dhampur Bio Organics is on one of our India lists: Undervalued stocks.

Dhampur Bio Organics Ltd earned ₹37.0 Cr of net profit in the Jun 2026 quarter. Full-year FY26 profit was ₹25.0 Cr. That is 6.9% of the quarter's revenue. The same quarter a year earlier lost ₹22.0 Cr. 5 of the last 12 reported quarters were loss-making.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY26 profit was ₹25.0 Cr (+66.7% on the year before).

Dhampur Bio Organics Ltd reported ₹533 Cr of revenue in the Jun 2026 quarter, +8.3% on the same quarter a year earlier. The last full year, FY26, came in at ₹2,109 Cr. The last four reported quarters add to ₹2,037 Cr.

Revenue is everything the company billed its customers in the period.

A growth rate over several years is not shown, because there are too few years of figures to work one out properly.

FY26 revenue was ₹2,109 Cr, +13.3% on the year before.

Is growth speeding up? Revenue over the last 12 months grew +8.0%, against +8.0% a year over the last 8 quarters (stabilising).

Dhampur Bio Organics Ltd's operating margin was 1.7% in the Jun 2026 quarter, 0.1 percentage points lower than the same quarter a year ago. Across 5 years it has been between 6.0% and 12.0%. The latest quarter is below every full year in that period.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed −0.1 percentage points on the year while gross margin changed +2.6 points. So the drop came mostly from the gross margin, which means input costs and prices charged.

Over the last 3 years, 290% of Dhampur Bio Organics Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹220 Cr of operating cash against ₹25.0 Cr of profit. After ₹36.0 Cr of spending on assets, ₹184 Cr was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 290% of profit came in as cash: the cash cycle got 96 days shorter between FY22 and FY26, so cash that used to wait in the business now arrives sooner.

What to look at next: the bigger use of cash is spending on new assets, at 2.2× depreciation over three years. The next section checks what that spending is building.

Dhampur Bio Organics Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 216 days in FY26, down from 312 days in FY22. It spent ₹349 Cr on assets over the last 3 years. Customers take 11 days to pay, and stock sits for 231 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹2,109 Cr, each day of that cycle ties up about ₹5.8 Cr, so roughly ₹1,248 Cr is tied up in the business at any time.

FY26: customers took 11 days to pay and stock sat for 231 days, about 7.6 months of sales sitting as stock, for a full cycle of 216 days, shorter than FY22's 312.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 231 days. Customers pay about 11 days after that. Suppliers are paid at 26 days. Together that makes the 216-day cycle.

Spending on assets: ₹349 Cr over the last 3 years, against ₹162 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹1.0 Cr (FY26): assets paid for that are not earning yet.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

Dhampur Bio Organics Ltd's P/E is 34.4×, near the high end of its own history: higher than 80% of past readings. Its usual P/E (the middle reading) is 23.9×, over 4.1 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

Why the multiple is where it is: over the past year earnings per share moved +71.5% while the price moved +73.8%. The price did better than earnings, which pushed the multiple up within its own range.

Where the price move came from: over 3 years the price moved −6.2% a year; about −38.1% a year came from earnings growth and about +31.9 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple.

Dhampur Bio Organics Ltd's business is turning around. Profit growth has swung from −100.0% at its low to +66.7%, rising from a low 2 quarters ago, with ROCE steady at 12.1%. This is based on 12 quarters of 4 measures.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Why it matters: a turn in growth is often where a bigger change starts. The lines say a turn is forming, so the question is whether the next quarters confirm it.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

MGMT fail, see Step 6 batch reports for detail.

Checked 4 March 2026.

Dhampur Bio Organics Ltd earned a ROCE of 5% in FY26. That is up from a low of 4% in FY25. Its return on capital used (ROIC) is 9.8 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses.

Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.

It comes from a 1.2% net margin and 0.91× asset turnover (sales divided by assets).

Why the return is what it is (FY26): a 1.2% net margin × 0.91× asset turnover × 2.26× leverage (assets divided by equity) ≈ 2.5% on equity. The margin does its share; borrowing is a big part of it.

The key test, return on capital used minus the cost of capital: 2.2% − 12.0% = −9.8 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve.

Dhampur Bio Organics Ltd has total debt of ₹1,060 Cr against shareholder equity of ₹1,027 Cr as of Jun 2026, so its debt is 1.03× its equity. Year by year, that ratio went from 0.95 in FY22 to 1.03 in FY26. Keep that borrowing in mind when reading the returns on this page.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

Domestic institutions cut their stake in Dhampur Bio Organics Ltd by 1.0 percentage points over 8 quarters, the biggest change among its owners. Domestic institutions now own 0.4% of the company. Foreign institutions moved −0.3 points over the same period, to 0.6%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.

Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.

Over the last two years: Domestic institutions: −1.0 points over 8 quarters, to 0.4%; Foreign institutions: −0.3 points over 8 quarters, to 0.6%; Promoters: +0.2 points over 8 quarters, to 51.0%.

Why the owners changed: domestic institutions drove it (−1.0 points). They reduced their stake.

For Dhampur Bio Organics Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

56.2 out of 100, rank 4 of 21 in Sugar, with 78% of the evidence available.

Dhampur Bio Organics Ltd scores 56.2 out of 100 against the 21 companies it is compared with in Sugar, ranking 4. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

The four parts add up to the total exactly: 21 + 7.7 + 10.3 + 17.2 = 56.2. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Dhampur Bio Organics ranks 4 of 21 Sugar companies on the 4-Factor Sector Score, with 56.2 out of 100.

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Sugar, all 21 compared on one page.

Dhampur Bio Organics is the 15th largest of 21 Sugar companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Andhra Sugars, Godavari Biorefineries and Dhampur Sugar Mills. Just below it: Dwarikesh Sugar Industries, Magadh Sugar & Energy and Zuari Industries.

Sugar companies close in size

12. Andhra Sugars Ltd ₹1,065 crore
13. Godavari Biorefineries Ltd ₹1,044 crore
14. Dhampur Sugar Mills Ltd ₹1,026 crore
15. Dhampur Bio Organics Ltd ₹779 crore
16. Dwarikesh Sugar Industries Ltd ₹760 crore
17. Magadh Sugar & Energy Ltd ₹712 crore
18. Zuari Industries Ltd ₹705 crore

All 21 Sugar companies, largest first

Companies close in size in other industries

1749. Vision Infra Equipment Solutions Ltd ₹782 crore · Trading
1750. Sudarshan Pharma Industries Ltd ₹780 crore · Trading
1751. Dhampur Bio Organics Ltd ₹779 crore
1752. Namo eWaste Management Ltd ₹778 crore · Recycling
1753. A B Infrabuild Ltd ₹777 crore · Construction - Civil/Turnkey

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.